Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

BIIB061

BIIB061 capsules for oral administration

DRUG

Placebo

BIIB061 matching placebo capsules

DRUG

14C-BIIB061

Radiolabeled containing 14C-BIIB061 ≤ 500 nCi.

Trial Locations (2)

Research Site, Evansville

Research Site, Madison